Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.
Phase of Trial: Phase IV
Latest Information Update: 07 Jan 2019
Price : $35 *
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Paracetamol
- Indications Coronary artery disease; Myocardial infarction
- Focus Pharmacokinetics
- Acronyms The GASTRIM study
- 24 Jan 2017 Planned End Date changed from 1 Oct 2015 to 8 Jun 2017.
- 24 Jan 2017 Planned primary completion date changed from 1 Oct 2015 to 8 Jun 2017.
- 24 Jan 2017 Status changed from not yet recruiting to recruiting.